News
STAY TUNED: ELIXI NEWS FROM THE WORLD
Meet our AI- driven robot
31 July 2024
We are more than proud to announce that, through a tight collaboration with SUPSI (Università della Svizzera Italiana) and our partner KeepOne Swiss Vision Technology, we have developed the first-ever automated quality control system in Switzerland, enthusiastically approved by Swissmedic. This…
Please join us in congratulating Fabio for his first successful year in Elixi!
9 January 2024
Let's put a face to a name! Let us introduce you to one of the "pillars" of our organisation, our Head of Quality and Medical department, the mighty Fabio Macchi! Fabio joined us exactly one year ago, in a moment that has been pivotal in the development of Elixi towards a truly wide ranging,…
Come and meet us at Expopharm 2023! 27 -30 September in DÜSSELDORF.
13 September 2023
Come and meet us at Expopharm 2023! 27 -30 September in DÜSSELDORF. Our colleagues Luca Schincaglia and Marco Ferrario will be there and happy to chat with you! #expopharm2023 #expopharm https://lnkd.in/ec-ex7br
September is the World Alzheimer’s awareness Month 2023
8 September 2023
The campaign theme for World Alzheimer’s Month 2023 is ‘Never too early never too late’. The ‘Never too early, never too late‘ campaign aims to underscore the pivotal role of identifying risk factors and adopting proactive risk reduction measures to delay, and potentially even prevent, the onset of…
Elixi International is proud to announce the opening of our subsidiary in Singapore!
4 July 2023
Today is the day! Elixi International is going to Singapore! Today we are thrilled to announce the opening of our subsidiary in Singapore, Elixi Pharma pte. ltd.! We are very proud of this significant milestone that shows our continuous commitment to global growth and our dedication to better…
FDA Approves First Cellular Therapy to Treat Patients with Type 1 Diabetes
29 June 2023
First Cellular Therapy to Treat Patients with Type 1 Diabetes has been approved by FDA. It is the first allogeneic (donor) pancreatic islet cellular therapy made from deceased donor pancreatic cells for the treatment of type 1 diabetes. “Severe hypoglycemia is a dangerous condition that can lead to…
A new class of medicines to treat pediatric type 2 diabetes
25 June 2023
“Compared to adults, children with type 2 diabetes have limited treatment options, even though the disease and symptom onset generally progress more rapidly in children,” The FDA has approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin hydrochloride) as additions to diet and…
We join in celebrating Global Wellness Day!
10 June 2023
“One day can change your whole life,”... well, that day can be today! Global Wellness Day is a social project dedicated to living well. The purpose of Global Wellness Day is to ask the question, even if for just one day, “How can I live a healthier and better life?”, to direct the thoughts of both…
Targeted Therapy Vorasidenib Offers Hope for Deadly Brain Tumors
5 June 2023
A new promising therapy option from the American Society of Clinical Oncology Congress in Chicago. Targeted Therapy Vorasidenib Offers Hope for Deadly Brain Tumors https://lnkd.in/gcJTGrhz